Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Evolocumab on Coronary Endothelial Function

Trial Profile

Effect of Evolocumab on Coronary Endothelial Function

Phase of Trial: Phase II

Latest Information Update: 18 May 2018

At a glance

  • Drugs Evolocumab (Primary)
  • Indications Coronary artery disease
  • Focus Biomarker; Therapeutic Use
  • Acronyms EVOLVE
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 04 May 2018 Status changed from not yet recruiting to recruiting.
    • 20 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top